openPR Logo
Press release

2025-2034 Hemostats Market Evolution: Disruptions, Innovations, and Untapped Opportunities

06-27-2025 09:26 AM CET | Health & Medicine

Press release from: The Business Research Company

Hemostats Market Size

Hemostats Market Size

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Is the Expected CAGR for the Hemostats Market Through 2025?
In recent times, there has been a substantial increase in the size of the hemostats market. It is projected to expand from $3.37 billion in 2024 to reach $3.59 billion in 2025 with a compound annual growth rate (CAGR) of 6.5%. Factors contributing to the historical growth include advancements in surgical procedures, increased elderly population, prevalence of chronic illnesses and coagulation disorders, growth in cardiovascular surgeries, and orthopedic applications.

What's the Projected Size of the Global Hemostats Market by 2029?
The market for hemostats is projected to witness substantial expansion in the upcoming years, reaching a valuation of $4.67 billion by 2029 at a CAGR of 6.8%. This projected growth in the forecast period can be tied to a range of factors including readiness for emergencies and pandemic response, the development of global healare infrastructure, increased preference for minimally invasive surgeries, broadening usage in diverse specialties, as well as an emphasis on biocompatibility. Product innovation, advancements in hemostatic technologies, and a continued focus on minimally invasive procedures represent some major trends for the forecast period.

View the full report here:
https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Top Growth Drivers in the Hemostats Industry: What's Accelerating the Market?
The hemostat market's expansion is anticipated to be driven by a rise in surgical procedures. Surgical procedures encompass every invasive method employed on an individual to explore or address a pathological condition. Hemostats play a vital role in these procedures because they mitigate blood loss during surgery. For example, in September 2023, the Lebanon-based International Society of Aesthetic Plastic Surgery reported an 11.2% aggregate upsurge in operations conducted by plastic surgeons in 2022. This included over 14.9 million surgical procedures and 18.8 million non-surgical procedures performed globally. Furthermore, both surgical and non-surgical procedures exhibited growth compared to the previous survey, increasing 16.7% and 7.2% respectively. As a result, the surge in surgical procedures is stimulating the growth of the hemostat market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8226&type=smp

What Trends Will Shape the Hemostats Market Through 2029 and Beyond?
A primary trend in the hemostats market is attributed to technological innovation. Leading corporations within the hemostats market are making strides forward with their latest technologies and market research. For instance, in March 2022, Baxter, a US-based healare company announced the introduction of PERCLOT Absorbable Hemostatic Powder in the U.S. market. PERCLOT is prepped and ready for use as a passive, absorbable hemostatic powder formulated for patients with an unimpaired coagulation process to control mild bleeding. The American launch of PERCLOT ensures surgeons have full access to a complete variety of active and passive hemostatic products for controlling bleeding, thus enhancing patient care.

What Are the Main Segments in the Hemostats Market?
The hemostats market covered in this report is segmented -

1) By Type: Thrombin-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats
2) By Product: Active Hemostats, Passive Hemostats, Combination Hemostats, Other Products
3) By Formulation: Matrix And Gel Hemostats, Sheet And Pad Hemostats, Sponge Hemostats, Powder Hemostats
4) By Application: Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Other Applications

Subsegments:
1) By Thrombin-Based Hemostats: Topical Thrombin, Lyophilized Thrombin
2) By Oxidized Regenerated Cellulose-Based Hemostats: Pads, Granules
3) By Combination Hemostats: Thrombin And Gelatin Combinations, Thrombin And Collagen Combinations
4) By Gelatin-Based Hemostats: Gelfoam, Gelatin Sponge
5) By Collagen-Based Hemostats: Collagen Sheets, Collagen Powder

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8226&type=smp

Which Top Companies are Driving Growth in the Hemostats Market?
Major companies operating in the hemostats market are B. Braun Melsungen AG, Baxter International Inc., Integra LifeSciences Corporation, Becton inson and Company, Teleflex Incorporated, Medtronic PLC, Hemostasis LLC, Stryker Corporation, Advanced Medical Solutions Group PLC, Samyang Holdings Corporation, Gelita Medical GmbH, CryoLife Inc., CuraMedical B.V., Meril Life Sciences Pvt. Ltd., Beijing Datsing Bio-Tech Co. Ltd., Zhonghui Shengxi (Beijing) Medical Technology Co. Ltd., Biotemed Inc., Biom'up SA, Shandong Foryou Medical Devices Co. Ltd., Z-Medica LLC, Anika Therapeutics Inc., Metalcraft Solutions Inc.

Which Regions Will Dominate the Hemostats Market Through 2029?
North America was the largest region in the hemostats market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostats market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8226

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release 2025-2034 Hemostats Market Evolution: Disruptions, Innovations, and Untapped Opportunities here

News-ID: 4084657 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Hemostats

Absorbable Hemostats Market Overview
In today's dynamic global economy, the absorbable hemostats market is emerging as a beacon of opportunity and innovation. With rapid technological advancements, evolving consumer demands, and proactive government policies shaping the landscape, this sector is setting the stage for transformative change. Our in-depth analysis delves into historical market trends, current dynamics, and future projections, providing industry leaders, investors, and decision-makers with the strategic insights needed to navigate this competitive terrain. 𝐆𝐞𝐭
Hemostats Market Insights, Forecast to 2031
A new Report by DataM Intelligence, titled "Hemostats Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031,"" offers a comprehensive analysis of the industry, which comprises insights on the Hemostats market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Hemostats market has been growing significantly
Hemostats Market Size, Outlook, Overview 2024-2033
The hemostats market size has grown strongly in recent years. It will grow from $3.17 billion in 2023 to $3.46 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to surgical advancements, rising geriatric population, chronic diseases and coagulation disorders, expansion of cardiovascular surgeries, orthopedic applications. The hemostats market size is expected to see strong growth in
Hemostats Market worth $3.7 billion by 2028
Hemostats Market in terms of revenue was estimated to be worth $2.7 Billion in 2023 and is poised to reach $3.7 Billion by 2028, growing at a CAGR of 6.7% from 2023 to 2028 according to a new report by MarketsandMarkets. The significant growth in the number of hospitals and surgical centers is expected to support the growth of the hemostats market, as these are key end users of hemostats. The
Global Hemostats and Tissue Sealants Market
Global Hemostats and Tissue Sealants Market –Industry Analysis and Forecast 2018-2026 – By Product Type, Application, End-user, and Region. Global Hemostats and Tissue Sealants Market was valued US$ 2.78 Bn in 2017 and is expected to reach US$ 5.29 Bn by 2026, at a CAGR of 8.37% during a forecast period. Increasing incidence of chronic diseases, the wide range of applications, patient safety & quick recovery, number of surgeries and growing aging
Hemostats Market worth $3.03 billion by 2023
According to the new market research “"Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023", The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%. Don’t miss out on business opportunities in Hemostats Market . Speak to our